AG˹ٷ

STOCK TITAN

[Form 4] Natera, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 Overview � Natera, Inc. (NTRA)

The filing discloses that co-founder and director Jonathan Sheena sold Natera common stock on two separate dates under previously adopted Rule 10b5-1 trading plans.

  • 18 Jun 2025: Direct sale of 3,070 shares at a weighted-average price of $167.2869 per share. Direct ownership after the sale is 248,774 shares.
  • 16 Jun 2025: Eight block sales by Caraluna 1 Trust and Caraluna 2 Trust (both held for the benefit of trust beneficiaries and disclaimed for beneficial-ownership purposes). The trusts sold an aggregate of 3,000 shares at weighted-average prices ranging from $162.04&Բ;�&Բ;$165.55 per share. Post-transaction holdings were 38,379�37,282 shares per trust line item.

No derivative security transactions were reported. All sales were executed automatically under the trading plans adopted on 11 Dec 2024 (direct holdings) and 7 Jun 2024 (trust holdings), limiting discretionary timing by the insider.

In total, the reporting person disposed of 6,070 shares, representing a low-single-digit percentage of his reported direct and indirect ownership. While insider selling can be perceived negatively, the modest size relative to the remaining stake and the use of pre-arranged 10b5-1 plans mitigate signal risk.

Panoramica del Modulo 4 � Natera, Inc. (NTRA)

La comunicazione rivela che il cofondatore e direttore Jonathan Sheena ha venduto azioni ordinarie di Natera in due date distinte, seguendo piani di trading precedentemente adottati conformi alla Regola 10b5-1.

  • 18 giugno 2025: Vendita diretta di 3.070 azioni a un prezzo medio ponderato di $167,2869 per azione. La proprietà diretta dopo la vendita è di 248.774 azioni.
  • 16 giugno 2025: Otto vendite a blocchi effettuate da Caraluna 1 Trust e Caraluna 2 Trust (entrambi detenuti a beneficio dei beneficiari del trust e esclusi ai fini della proprietà effettiva). I trust hanno venduto complessivamente 3.000 azioni a prezzi medi ponderati compresi tra $162,04&Բ;�&Բ;$165,55 per azione. Le partecipazioni post-transazione erano comprese tra 38.379 e 37.282 azioni per ciascun trust.

Non sono state segnalate transazioni su strumenti derivati. Tutte le vendite sono state eseguite automaticamente secondo i piani di trading adottati l'11 dicembre 2024 (partecipazioni dirette) e il 7 giugno 2024 (partecipazioni dei trust), limitando la discrezionalità temporale dell'insider.

In totale, la persona segnalante ha ceduto 6.070 azioni, rappresentando una percentuale bassa a una cifra singola rispetto alla sua proprietà diretta e indiretta dichiarata. Sebbene la vendita da parte di un insider possa essere vista negativamente, la dimensione modesta rispetto alla quota residua e l'uso di piani 10b5-1 predefiniti riducono il rischio di segnali negativi.

Resumen del Formulario 4 � Natera, Inc. (NTRA)

La presentación revela que el cofundador y director Jonathan Sheena vendió acciones comunes de Natera en dos fechas diferentes bajo planes de negociación adoptados previamente conforme a la Regla 10b5-1.

  • 18 de junio de 2025: Venta directa de 3,070 acciones a un precio promedio ponderado de $167.2869 por acción. La propiedad directa después de la venta es de 248,774 acciones.
  • 16 de junio de 2025: Ocho ventas en bloque por parte de Caraluna 1 Trust y Caraluna 2 Trust (ambos mantenidos para el beneficio de los beneficiarios del fideicomiso y renunciando a la propiedad beneficiosa). Los fideicomisos vendieron un total de 3,000 acciones a precios promedio ponderados que oscilaron entre $162.04&Բ;�&Բ;$165.55 por acción. Las participaciones posteriores a la transacción fueron de 38,379�37,282 acciones por cada fideicomiso.

No se reportaron transacciones con valores derivados. Todas las ventas se ejecutaron automáticamente bajo los planes de negociación adoptados el 11 de diciembre de 2024 (participaciones directas) y el 7 de junio de 2024 (participaciones en fideicomisos), limitando la discreción temporal del insider.

En total, la persona que reporta dispuso de 6,070 acciones, representando un porcentaje bajo de un solo dígito respecto a su propiedad directa e indirecta reportada. Aunque la venta por parte de un insider puede percibirse negativamente, el tamaño modesto en relación con la participación restante y el uso de planes 10b5-1 preestablecidos mitigan el riesgo de señales negativas.

Form 4 개요 � Natera, Inc. (NTRA)

신고서에 따르� 공동 창립자이� 이사� Jonathan Sheena가 이전� 채택� Rule 10b5-1 거래 계획� 따라 � 차례� 걸쳐 Natera 보통주를 매각했습니다.

  • 2025� 6� 18�: 주당 가중평� 가� $167.28693,070� 직접 매각. 매각 � 직접 보유 주식은 248,774�입니�.
  • 2025� 6� 16�: Caraluna 1 TrustCaraluna 2 Trust가 각각 8건의 블록 매도(신탁 수혜� 이익� 위해 보유되었으며 실질 소유� 목적� 권리� 포기�). � 신탁은 � 3,000�� 주당 가중평� 가� $162.04&Բ;�&Բ;$165.55� 매각했습니다. 거래 � � 신탁� 보유 주식은 38,379Ŧ37,282�옶습니�.

파생상품 거래� 보고되지 않았습니�. 모든 매도� 2024� 12� 11�(직접 보유�)� 2024� 6� 7�(신탁 보유�)� 채택� 거래 계획� 따라 자동으로 실행되어 내부자의 임의 타이밍 조정� 제한했습니다.

� 신고인은 6,070�� 처분했으�, 이는 신고� 직접 � 간접 보유 지분의 � 자릿� 소수 퍼센트에 해당합니�. 내부� 매도� 부정적으로 인식� � 있으�, 남은 지� 대� 규모가 작고 사전 설정� 10b5-1 계획� 사용� 점이 신호 위험� 완화합니�.

Présentation du Formulaire 4 � Natera, Inc. (NTRA)

Le dépôt révèle que le cofondateur et directeur Jonathan Sheena a vendu des actions ordinaires de Natera à deux dates distinctes, selon des plans de négociation adoptés précédemment conformément à la règle 10b5-1.

  • 18 juin 2025 : Vente directe de 3 070 actions à un prix moyen pondéré de 167,2869 $ par action. La détention directe après la vente s’élève à 248 774 actions.
  • 16 juin 2025 : Huit ventes en bloc par Caraluna 1 Trust et Caraluna 2 Trust (tous deux détenus au bénéfice des bénéficiaires du trust et déniés à des fins de propriété effective). Les trusts ont vendu un total de 3 000 actions à des prix moyens pondérés allant de 162,04 $ à 165,55 $ par action. Les avoirs après transaction étaient de 38 379 à 37 282 actions par trust.

Aucune transaction sur titres dérivés n’a été rapportée. Toutes les ventes ont été exécutées automatiquement selon les plans de négociation adoptés le 11 décembre 2024 (détentions directes) et le 7 juin 2024 (détentions en trusts), limitant ainsi la discrétion temporelle de l’initié.

Au total, la personne déclarant a cédé 6 070 actions, représentant un faible pourcentage à un chiffre de sa détention directe et indirecte déclarée. Bien que la vente par un initié puisse être perçue négativement, la taille modeste par rapport à la participation restante et l’utilisation de plans 10b5-1 préétablis atténuent le risque de signal.

Übersicht Formular 4 � Natera, Inc. (NTRA)

Die Meldung zeigt, dass Mitgründer und Direktor Jonathan Sheena Natera-Stammaktien an zwei verschiedenen Terminen im Rahmen zuvor angenommener Rule 10b5-1 Handelspläne verkauft hat.

  • 18. Juni 2025: Direkter Verkauf von 3.070 Aktien zu einem gewichteten Durchschnittspreis von 167,2869 $ pro Aktie. Der direkte Besitz nach dem Verkauf beträgt 248.774 Aktien.
  • 16. Juni 2025: Acht Blockverkäufe durch Caraluna 1 Trust und Caraluna 2 Trust (beide zum Nutzen der Treugeber gehalten und für Zwecke des wirtschaftlichen Eigentums abgelehnt). Die Trusts verkauften insgesamt 3.000 Aktien zu gewichteten Durchschnittspreisen zwischen 162,04 $ � 165,55 $ pro Aktie. Der Bestand nach der Transaktion lag bei 38.379�37.282 Aktien je Trust.

Keine Derivattransaktionen wurden gemeldet. Alle Verkäufe erfolgten automatisch gemäß den am 11. Dezember 2024 (direkter Besitz) und 7. Juni 2024 (Trust-Besitz) angenommenen Handelsplänen, wodurch die diskretionäre Timing-Möglichkeit des Insiders eingeschränkt wurde.

Insgesamt veräußerte die meldende Person 6.070 Aktien, was einen niedrigen einstelligen Prozentsatz ihres gemeldeten direkten und indirekten Besitzes darstellt. Obwohl Insiderverkäufe negativ wahrgenommen werden können, mildern die geringe Größe im Verhältnis zum verbleibenden Anteil und die Nutzung vorab festgelegter 10b5-1-Pläne das Signalisierungsrisiko.

Positive
  • None.
Negative
  • Insider disposition: Co-founder Jonathan Sheena sold a total of 6,070 shares (�$1.0 m) across direct and trust accounts, which may be perceived as a bearish signal by some investors.

Insights

TL;DR: Co-founder sells 6,070 shares (�$1.0 m) via 10b5-1; modest versus 325k+ remaining stake, limited directional signal.

The direct sale (3,070 shares) and trust sales (3,000 shares) equate to roughly $1.0 million in total proceeds, a minimal fraction of Mr. Sheena’s combined direct (248,774) and indirect (~75,000) share base. Because transactions were executed under Rule 10b5-1 plans adopted months earlier, they were likely scheduled in advance, reducing concerns of information asymmetry. No option exercises, grants, or derivative positions were reported, so dilution mechanics are unchanged. Historically, insider selling of <5 % of holdings tends to have limited predictive value for price performance, especially when tied to automated plans. Therefore, I classify the filing as neutral for valuation and sentiment.

TL;DR: Routine 10b5-1 plan activity; governance impact immaterial, maintains alignment through sizable residual stake.

From a governance lens, the disclosure satisfies Section 16 obligations and clearly footnotes the 10b5-1 framework, enhancing transparency. The insider retains substantial ownership, preserving long-term alignment with shareholders. No red flags—such as undisclosed derivatives, abrupt plan amendments, or concentrated position exits—are present. Consequently, I view the event as routine and not impactful to board oversight or shareholder rights.

Panoramica del Modulo 4 � Natera, Inc. (NTRA)

La comunicazione rivela che il cofondatore e direttore Jonathan Sheena ha venduto azioni ordinarie di Natera in due date distinte, seguendo piani di trading precedentemente adottati conformi alla Regola 10b5-1.

  • 18 giugno 2025: Vendita diretta di 3.070 azioni a un prezzo medio ponderato di $167,2869 per azione. La proprietà diretta dopo la vendita è di 248.774 azioni.
  • 16 giugno 2025: Otto vendite a blocchi effettuate da Caraluna 1 Trust e Caraluna 2 Trust (entrambi detenuti a beneficio dei beneficiari del trust e esclusi ai fini della proprietà effettiva). I trust hanno venduto complessivamente 3.000 azioni a prezzi medi ponderati compresi tra $162,04&Բ;�&Բ;$165,55 per azione. Le partecipazioni post-transazione erano comprese tra 38.379 e 37.282 azioni per ciascun trust.

Non sono state segnalate transazioni su strumenti derivati. Tutte le vendite sono state eseguite automaticamente secondo i piani di trading adottati l'11 dicembre 2024 (partecipazioni dirette) e il 7 giugno 2024 (partecipazioni dei trust), limitando la discrezionalità temporale dell'insider.

In totale, la persona segnalante ha ceduto 6.070 azioni, rappresentando una percentuale bassa a una cifra singola rispetto alla sua proprietà diretta e indiretta dichiarata. Sebbene la vendita da parte di un insider possa essere vista negativamente, la dimensione modesta rispetto alla quota residua e l'uso di piani 10b5-1 predefiniti riducono il rischio di segnali negativi.

Resumen del Formulario 4 � Natera, Inc. (NTRA)

La presentación revela que el cofundador y director Jonathan Sheena vendió acciones comunes de Natera en dos fechas diferentes bajo planes de negociación adoptados previamente conforme a la Regla 10b5-1.

  • 18 de junio de 2025: Venta directa de 3,070 acciones a un precio promedio ponderado de $167.2869 por acción. La propiedad directa después de la venta es de 248,774 acciones.
  • 16 de junio de 2025: Ocho ventas en bloque por parte de Caraluna 1 Trust y Caraluna 2 Trust (ambos mantenidos para el beneficio de los beneficiarios del fideicomiso y renunciando a la propiedad beneficiosa). Los fideicomisos vendieron un total de 3,000 acciones a precios promedio ponderados que oscilaron entre $162.04&Բ;�&Բ;$165.55 por acción. Las participaciones posteriores a la transacción fueron de 38,379�37,282 acciones por cada fideicomiso.

No se reportaron transacciones con valores derivados. Todas las ventas se ejecutaron automáticamente bajo los planes de negociación adoptados el 11 de diciembre de 2024 (participaciones directas) y el 7 de junio de 2024 (participaciones en fideicomisos), limitando la discreción temporal del insider.

En total, la persona que reporta dispuso de 6,070 acciones, representando un porcentaje bajo de un solo dígito respecto a su propiedad directa e indirecta reportada. Aunque la venta por parte de un insider puede percibirse negativamente, el tamaño modesto en relación con la participación restante y el uso de planes 10b5-1 preestablecidos mitigan el riesgo de señales negativas.

Form 4 개요 � Natera, Inc. (NTRA)

신고서에 따르� 공동 창립자이� 이사� Jonathan Sheena가 이전� 채택� Rule 10b5-1 거래 계획� 따라 � 차례� 걸쳐 Natera 보통주를 매각했습니다.

  • 2025� 6� 18�: 주당 가중평� 가� $167.28693,070� 직접 매각. 매각 � 직접 보유 주식은 248,774�입니�.
  • 2025� 6� 16�: Caraluna 1 TrustCaraluna 2 Trust가 각각 8건의 블록 매도(신탁 수혜� 이익� 위해 보유되었으며 실질 소유� 목적� 권리� 포기�). � 신탁은 � 3,000�� 주당 가중평� 가� $162.04&Բ;�&Բ;$165.55� 매각했습니다. 거래 � � 신탁� 보유 주식은 38,379Ŧ37,282�옶습니�.

파생상품 거래� 보고되지 않았습니�. 모든 매도� 2024� 12� 11�(직접 보유�)� 2024� 6� 7�(신탁 보유�)� 채택� 거래 계획� 따라 자동으로 실행되어 내부자의 임의 타이밍 조정� 제한했습니다.

� 신고인은 6,070�� 처분했으�, 이는 신고� 직접 � 간접 보유 지분의 � 자릿� 소수 퍼센트에 해당합니�. 내부� 매도� 부정적으로 인식� � 있으�, 남은 지� 대� 규모가 작고 사전 설정� 10b5-1 계획� 사용� 점이 신호 위험� 완화합니�.

Présentation du Formulaire 4 � Natera, Inc. (NTRA)

Le dépôt révèle que le cofondateur et directeur Jonathan Sheena a vendu des actions ordinaires de Natera à deux dates distinctes, selon des plans de négociation adoptés précédemment conformément à la règle 10b5-1.

  • 18 juin 2025 : Vente directe de 3 070 actions à un prix moyen pondéré de 167,2869 $ par action. La détention directe après la vente s’élève à 248 774 actions.
  • 16 juin 2025 : Huit ventes en bloc par Caraluna 1 Trust et Caraluna 2 Trust (tous deux détenus au bénéfice des bénéficiaires du trust et déniés à des fins de propriété effective). Les trusts ont vendu un total de 3 000 actions à des prix moyens pondérés allant de 162,04 $ à 165,55 $ par action. Les avoirs après transaction étaient de 38 379 à 37 282 actions par trust.

Aucune transaction sur titres dérivés n’a été rapportée. Toutes les ventes ont été exécutées automatiquement selon les plans de négociation adoptés le 11 décembre 2024 (détentions directes) et le 7 juin 2024 (détentions en trusts), limitant ainsi la discrétion temporelle de l’initié.

Au total, la personne déclarant a cédé 6 070 actions, représentant un faible pourcentage à un chiffre de sa détention directe et indirecte déclarée. Bien que la vente par un initié puisse être perçue négativement, la taille modeste par rapport à la participation restante et l’utilisation de plans 10b5-1 préétablis atténuent le risque de signal.

Übersicht Formular 4 � Natera, Inc. (NTRA)

Die Meldung zeigt, dass Mitgründer und Direktor Jonathan Sheena Natera-Stammaktien an zwei verschiedenen Terminen im Rahmen zuvor angenommener Rule 10b5-1 Handelspläne verkauft hat.

  • 18. Juni 2025: Direkter Verkauf von 3.070 Aktien zu einem gewichteten Durchschnittspreis von 167,2869 $ pro Aktie. Der direkte Besitz nach dem Verkauf beträgt 248.774 Aktien.
  • 16. Juni 2025: Acht Blockverkäufe durch Caraluna 1 Trust und Caraluna 2 Trust (beide zum Nutzen der Treugeber gehalten und für Zwecke des wirtschaftlichen Eigentums abgelehnt). Die Trusts verkauften insgesamt 3.000 Aktien zu gewichteten Durchschnittspreisen zwischen 162,04 $ � 165,55 $ pro Aktie. Der Bestand nach der Transaktion lag bei 38.379�37.282 Aktien je Trust.

Keine Derivattransaktionen wurden gemeldet. Alle Verkäufe erfolgten automatisch gemäß den am 11. Dezember 2024 (direkter Besitz) und 7. Juni 2024 (Trust-Besitz) angenommenen Handelsplänen, wodurch die diskretionäre Timing-Möglichkeit des Insiders eingeschränkt wurde.

Insgesamt veräußerte die meldende Person 6.070 Aktien, was einen niedrigen einstelligen Prozentsatz ihres gemeldeten direkten und indirekten Besitzes darstellt. Obwohl Insiderverkäufe negativ wahrgenommen werden können, mildern die geringe Größe im Verhältnis zum verbleibenden Anteil und die Nutzung vorab festgelegter 10b5-1-Pläne das Signalisierungsrisiko.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sheena Jonathan

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) X Other (specify below)
CO-FOUNDER
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 S 3,070(1) D $167.2869(2) 248,774 D
Common Stock 06/16/2025 S 200(3) D $162.4968(4) 38,582 I By Caraluna 1 Trust(5)
Common Stock 06/16/2025 S 203(3) D $163.4069(6) 38,379 I By Caraluna 1 Trust(5)
Common Stock 06/16/2025 S 550(3) D $164.8073(7) 37,829 I By Caraluna 1 Trust(5)
Common Stock 06/16/2025 S 547(3) D $165.4829(8) 37,282 I By Caraluna 1 Trust(5)
Common Stock 06/16/2025 S 176(3) D $162.5178(9) 38,606 I By Caraluna 2 Trust(5)
Common Stock 06/16/2025 S 200(3) D $163.1(10) 38,406 I By Caraluna 2 Trust(5)
Common Stock 06/16/2025 S 425(3) D $164.6398(11) 37,981 I By Caraluna 2 Trust(5)
Common Stock 06/16/2025 S 699(3) D $165.4079(12) 37,282 I By Caraluna 2 Trust(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.7250 to $167.6950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.04 to $162.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.12 to $163.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.45 to $165.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.48 to $165.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.04 to $162.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.08 to $163.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.10 to $165.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.16 to $165.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many NTRA shares did co-founder Jonathan Sheena sell according to the June 2025 Form 4?

The Form 4 shows aggregate sales of 6,070 common shares (3,070 direct and 3,000 via family trusts).

What were the sale prices for the NTRA insider transactions?

Weighted-average prices ranged from $162.04 to $167.29 per share as detailed in the footnotes.

Were the Natera insider sales made under a 10b5-1 trading plan?

Yes. The direct sale plan was adopted on 11 Dec 2024, and the trust sale plan was adopted on 7 Jun 2024.

How many NTRA shares does Jonathan Sheena still own after these transactions?

He directly owns 248,774 shares; indirect trust holdings range from 37,282 to 38,606 shares per trust position.

Did the Form 4 report any derivative security activity?

No. No options, warrants, or other derivatives were acquired or disposed of in this filing.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

21.64B
132.34M
3.2%
96.66%
2.72%
Diagnostics & Research
Services-medical Laboratories
United States
AUSTIN